Skip to main navigation Skip to search Skip to main content

Leveraging valine-restriction-induced DNA damage for targeted cancer therapy

Research output: Contribution to journalComment/debate

Abstract

Metabolite microenvironment shapes cancer treatment strategies. In a recent paper in Nature, Jin et al.1 demonstrate that valine deprivation triggers HDAC6 entry into the nucleus, leading to accumulation of DNA damage that could be harnessed for targeted cancer therapy.

Original languageEnglish
Pages (from-to)468-470
Number of pages3
JournalMolecular Cell
Volume85
Issue number3
DOIs
StatePublished - 6 Feb 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Leveraging valine-restriction-induced DNA damage for targeted cancer therapy'. Together they form a unique fingerprint.

Cite this